Case Report of Breakthrough Long COVID and the Use of Nirmatrelvir-Ritonavir [post]

Linda N. Geng, Hector F. Bonilla, Robert W. Shafer, Mitchell G. Miglis, Phillip C. Yang
2022 unpublished
Post-Acute Sequelae of SARS-CoV-2 (PASC), or long COVID, is a major public health problem. Encouraging data suggest that vaccination can reduce the risk of PASC. We report a cautionary case of breakthrough PASC and its resolution following a course of the novel combination antiviral nirmatrelvir-ritonavir.
doi:10.21203/ fatcat:lo4leycknva7rh5cd5ukveefci